New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux

R. T. Kershen, A. Atala

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Clinical experience over the last two decades has demonstrated that the endoscopic correction of primary vesicoureteral reflux and urinary incontinence caused by intrinsic sphincteric dysfunction is both possible and effective. The ideal material for use in these regards has yet to be developed. As a result, there has been a continuing research effort directed towards the development of new injectable substances. Nonautologous substances, such as Teflon, collagen, and Deflux, and autologous substances such as fat, chondrocytes and muscle, have been used either clinically or are under investigation. Although the ideal substance has yet to be determined, many of the substances currently under development appear promising. The use of a particular substance may best be determined by the clinical circumstance involving each individual patient.

Original languageEnglish
Pages (from-to)81-94
Number of pages14
JournalUrologic Clinics of North America
Volume26
Issue number1
StatePublished - Mar 9 1999
Externally publishedYes

Fingerprint

Vesico-Ureteral Reflux
Polytetrafluoroethylene
Urinary Incontinence
Chondrocytes
Collagen
Fats
Muscles
Injections
Research
Therapeutics
deflux

ASJC Scopus subject areas

  • Urology

Cite this

New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. / Kershen, R. T.; Atala, A.

In: Urologic Clinics of North America, Vol. 26, No. 1, 09.03.1999, p. 81-94.

Research output: Contribution to journalArticle

@article{2ae5f7018219413e8bd69505ac0e827d,
title = "New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux",
abstract = "Clinical experience over the last two decades has demonstrated that the endoscopic correction of primary vesicoureteral reflux and urinary incontinence caused by intrinsic sphincteric dysfunction is both possible and effective. The ideal material for use in these regards has yet to be developed. As a result, there has been a continuing research effort directed towards the development of new injectable substances. Nonautologous substances, such as Teflon, collagen, and Deflux, and autologous substances such as fat, chondrocytes and muscle, have been used either clinically or are under investigation. Although the ideal substance has yet to be determined, many of the substances currently under development appear promising. The use of a particular substance may best be determined by the clinical circumstance involving each individual patient.",
author = "Kershen, {R. T.} and A. Atala",
year = "1999",
month = "3",
day = "9",
language = "English",
volume = "26",
pages = "81--94",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux

AU - Kershen, R. T.

AU - Atala, A.

PY - 1999/3/9

Y1 - 1999/3/9

N2 - Clinical experience over the last two decades has demonstrated that the endoscopic correction of primary vesicoureteral reflux and urinary incontinence caused by intrinsic sphincteric dysfunction is both possible and effective. The ideal material for use in these regards has yet to be developed. As a result, there has been a continuing research effort directed towards the development of new injectable substances. Nonautologous substances, such as Teflon, collagen, and Deflux, and autologous substances such as fat, chondrocytes and muscle, have been used either clinically or are under investigation. Although the ideal substance has yet to be determined, many of the substances currently under development appear promising. The use of a particular substance may best be determined by the clinical circumstance involving each individual patient.

AB - Clinical experience over the last two decades has demonstrated that the endoscopic correction of primary vesicoureteral reflux and urinary incontinence caused by intrinsic sphincteric dysfunction is both possible and effective. The ideal material for use in these regards has yet to be developed. As a result, there has been a continuing research effort directed towards the development of new injectable substances. Nonautologous substances, such as Teflon, collagen, and Deflux, and autologous substances such as fat, chondrocytes and muscle, have been used either clinically or are under investigation. Although the ideal substance has yet to be determined, many of the substances currently under development appear promising. The use of a particular substance may best be determined by the clinical circumstance involving each individual patient.

UR - http://www.scopus.com/inward/record.url?scp=0033044264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033044264&partnerID=8YFLogxK

M3 - Article

C2 - 10086052

AN - SCOPUS:0033044264

VL - 26

SP - 81

EP - 94

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 1

ER -